CNTRICS final animal model task selection: control of attention.

CNTRICS final animal model task selection: control of attention.
复制标题

DOI:
10.1016/j.neubiorev.2012.05.009
复制
发表时间:
2013-11
影响因子:
8.2
通讯作者:
Robbins, T. W.
Robbins, T. W.
中科院分区:
医学1区
文献类型:
--
作者:
Lustig, C.;Kozak, R.;Sarter, M.;Young, J. W.;Robbins, T. W.

文献摘要

参考文献

被引文献

相似文献

精神分裂症与注意力受损有关。自上而下的注意力控制,定义为根据内部目标和表征引导和重新集中注意力的能力,被认知神经科学治疗研究确定为任务开发和研究的重要结构,以改善精神分裂症的认知(CNTRICS)倡议。最近的一次CNTRICS会议确定了三个任务通常使用啮齿动物模型具有较高的结构效度和进一步发展的承诺:5选择连续反应时间任务,5选择连续性能任务,和分心条件持续注意力任务。在这里,我们描述了他们的现状,包括他们的神经基板的数据,神经药理学操作和遗传影响的敏感性的证据,以及来自精神分裂症的认知缺陷的动物模型的数据。一个共同的优势是开发并行的人类任务,以促进与这些动物模型中的神经回路和药物开发研究的连接。最后,我们提出了改进测试所需步骤的建议,以便更好地代表精神分裂症所呈现的复杂生物学和行为学图像。
Schizophrenia is associated with impaired attention. The top-down control of attention, defined as the ability to guide and refocus attention in accordance with internal goals and representations, was identified by the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) initiative as an important construct for task development and research. A recent CNTRICS meeting identified three tasks commonly used with rodent models as having high construct validity and promise for further development: The 5-choice serial reaction time task, the 5-choice continuous performance task, and the distractor condition sustained attention task. Here we describe their current status, including data on their neural substrates, evidence for sensitivity to neuropharmacological manipulations and genetic influences, and data from animal models of the cognitive deficits of schizophrenia. A common strength is the development of parallel human tasks to facilitate connections to the neural circuitry and drug development research done in these animal models. We conclude with recommendations for the steps needed to improve testing so that it better represents the complex biological and behavioral picture presented by schizophrenia.
DOI: 10.1016/s0306-4522(02)00292-0
发表时间: 2002-01-01
期刊: NEUROSCIENCE
影响因子: 3.3
作者:
Arnold, HM;Burk, JA;Bruno, JP
通讯作者: Bruno, JP
DOI: 10.1016/s0304-3940(00)01019-3
发表时间: 2000-05-05
影响因子: 2.5
作者:
Cimadevilla, JM;Fenton, AA;Bures, J
通讯作者: Bures, J
DOI: 10.1007/s002130050446
发表时间: 1997-12-01
期刊: PSYCHOPHARMACOLOGY
影响因子: 3.4
作者:
Bushnell, PJ;Oshiro, WM;Padnos, BK
通讯作者: Padnos, BK
DOI: 10.1007/s00213-010-2065-7
发表时间: 2011-04-01
期刊: PSYCHOPHARMACOLOGY
影响因子: 3.4
作者:
Carli, Mirjana;Calcagno, Eleonora;Invernizzi, Roberto W.
通讯作者: Invernizzi, Roberto W.